July 24, 2013
J-CLEAR Chairman Iwao Kuwajima, second from the left An independent nonprofit organization that reviews clinical research concluded on July 20 that the data of the scandal-hit KYOTO Heart Study on the hypertension drug Diovan (valsartan) were manipulated possibly outside the...read more